Japan Cancer Treatment Facilities Market Size, Share, and COVID-19 Impact Analysis, By Treatment Type (Cancer Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Bone Marrow Transplantation, and Other Treatment Types), By Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Colorectal Cancer, Lung Cancer, and Other Cancer Types), By Provider (Hospitals and Cancer Centers), and Japan Cancer Treatment Facilities Market Insights, Industry Trend, Forecasts to 2035.

Japan Cancer Treatment Facilities Market Insights Forecasts to 2035

• The Japan Cancer Treatment Facilities Market Size Was Estimated at USD 3885.4 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.1% from 2025 to 2035
• The Japan Cancer Treatment Facilities Market Size is Expected to Reach USD 9151.7 Million by 2035

According to a research report published by Spherical Insights & Consulting, the Japan cancer treatment facilities market is anticipated to reach USD 9151.7 million by 2035, growing at a CAGR of 8.1% from 2025 to 2035. The Japan cancer treatment centers market is growing due to an aging population, increased cases of cancer, and advances in technology. Increased government investment in cancer research and the adoption of personalized medicine are also major drivers of this growth.

Market Overview

The Japan cancer treatment centers market refers to hospitals, cancer centers, and specialty clinics that offer oncology services such as surgery, chemotherapy, radiation therapy, immunotherapy, hormonal therapy, and bone marrow transplantation. Strengths are Japanese strong healthcare infrastructure, a system of 461 designated cancer treatment hospitals, solid R&D facilities such as the Japanese Foundation for Cancer Research and the National Cancer Center, and established oncology device and pharmaceutical sectors. Opportunities include growing proton and carbon-ion therapy facilities, combining AI and genomic precision medicine, increasing rural cancer care availability, and tapping into medical tourism expansion. Market drivers are the rapidly growing older population and increasing cancer incidence, and cancer is the top cause of death, with more than 380,000 annual fatalities. Technological innovations driving demand are precision therapies, particle and proton therapy, immunotherapy, and personalized oncology. Government policies under the Cancer Control Act, robust funding for oncology R&D, public partnerships, and efficient regulatory streams such as conditional approvals and Sakigake expediting, facilitate better access and innovation in cancer treatment.

Report Coverage

This research report categorizes the market for the Japan cancer treatment facilities market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan cancer treatment facilities market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan cancer treatment facilities market.

Driving Factors

The Japan cancer treatment facilities market is fueled by a rapidly expanding population of older people and increased prevalence of cancer, placing oncology treatment at the forefront of national priorities. The advanced technologies like proton therapy, immunotherapy, and precision medicine are being increasingly embraced, improving treatment efficacy. Government programs like the Cancer Control Act encourage early detection and equal access to healthcare. Besides, the Japanese robust healthcare system, well-funded R&D program, and increasing awareness among the public also assist in the growth and modernization of cancer treatment centers nationwide.

Restraining Factors

The Japan cancer treatment facilities market is hampered by restraints like high expenditure for high-tech therapies, decreased availability in rural areas, and a lack of oncology specialists. Also, lengthy treatment periods and complicated reimbursement processes can limit timely and extensive patient access.

Market Segmentation

The Japan cancer treatment facilities market share is classified into treatment type, cancer type, and provider.

• The cancer surgery segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan cancer treatment facilities market is segmented by treatment type into cancer surgery, chemotherapy, radiation therapy, immunotherapy, bone marrow transplantation, and other treatment types. Among these, the cancer surgery segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to its essential function in the management of early-stage cancers and curative ability. Extensive prevalence of operable cancers, innovation in minimally invasive methods, and extensive access to experienced surgeons are factors that lead to its predominance throughout the nation's health system.

• The blood cancer segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan cancer treatment facilities market is segmented by cancer type into blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, colorectal cancer, lung cancer, and other cancer types. Among these, the blood cancer segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is owing to its increasing incidence, particularly among the elderly. The technicality of treatment, involving specialized facilities for chemotherapy, bone marrow transplantation, and immunotherapy, fuels demand. Advances in targeted treatments and early detection also fuel the segment's dominant market share.

• The hospitals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan cancer treatment facilities market is segmented by provider into hospitals and cancer centers. Among these, the hospitals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to their extensive care facilities, modern infrastructure, and presence of multidisciplinary oncology teams. They treat large patient volumes, provide a variety of treatments under one roof, and have good government support, and thus are the first preference for the diagnosis and treatment of cancer.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan cancer treatment facilities market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Takeda Pharmaceutical
• Daiichi Sankyo
• Kyowa Kirin
• Pfizer Japan Inc.
• Astellas Pharma
• Novartis Pharma K.K.
• Chugai Pharmaceutical
• Shizuoka Cancer Center
• Bristol-Myers Squibb Company
• Sumitomo Pharma
• Ono Pharmaceutical
• Others

Recent Developments:

• In November 2021, Daiichi Sankyo launched Delytact, an oncolytic virus therapy, in Japan for treating malignant glioma. Approved based on a phase 2 trial, the HSV-1–based treatment showed improved one-year survival in glioblastoma patients previously treated with radiotherapy and chemotherapy.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan cancer treatment facilities market based on the below-mentioned segments:

Japan Cancer Treatment Facilities Market, By Treatment Type

• Cancer Surgery
• Chemotherapy
• Radiation Therapy
• Immunotherapy
• Bone Marrow Transplantation
• Other Treatment Types

Japan Cancer Treatment Facilities Market, By Cancer Type

• Blood Cancer
• Breast Cancer
• Prostate Cancer
• Gastrointestinal Cancer
• Colorectal Cancer
• Lung Cancer
• Other Cancer Types

Japan Cancer Treatment Facilities Market, By Provider

• Hospitals
• Cancer Centers